Are clinical trial data shared sufficiently today? No

BMJ (Online)

Volumn 347, Issue 7916, 2013, Pages

  Goldacre, Ben ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; ROFECOXIB; ROSIGLITAZONE;

CLINICAL STUDY; CLINICAL TRIAL (TOPIC); CONFIDENTIALITY; DRUG INDUSTRY; DRUG RESEARCH; DRUG SAFETY; INFORMATION DISSEMINATION; MEDICAL LITERATURE; PATIENT CODING; PRIORITY JOURNAL; PUBLICATION; SHORT SURVEY; UNITED KINGDOM; HUMAN; INFORMATION SYSTEM; METHODOLOGY; NOTE;

CLINICAL TRIALS AS TOPIC; HUMANS; INFORMATION DISSEMINATION; INFORMATION MANAGEMENT;

EID: 84880086726     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f1880     Document Type: Short Survey

References (14)

1. Song F, Parekh S, Hooper L, Loke YK, Ryder J, Sutton AJ, et al. Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess 2010;14:1-193. www.hta.ac.uk/fullmono/mon1408. pdf.
2. Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 2009;302:977-84.
3. Prayle AP, Hurley MN, Smyth AR. Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study. BMJ 2012;344:d7373.
4. Simes RJ. Publication bias: the case for an international registry of clinical trials. J Clin Oncol 1986;4:1529-41. (Pubitemid 17183579)
5. PhRMA Catalyst blog post, comments, 2 Feb 2013. http://catalyst.phrma. org/clinical-trials-discovering-and-sharing-knowledge/.
6. PhRMA press release, 4 Feb 2013. http://phrma.org/media/releases/phrma- statement-clinical-trials-bad-pharma
7. Godlee F, Groves T. The new BMJ policy on sharing data from drug and device trials. BMJ 2012;345:e7888.
8. Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Early Breast Cancer Trialists' Collaborative Group. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet 2011;378:1707-16.
9. Center for Outcomes Research and Evaluation. Yale University Open Data Access (YODA) Project. http://medicine.yale.edu/core/projects/yodap/index.aspx
10. European Medicines Agency. Release of data from clinical trials, 2012. www.ema.europa.eu/ema/index.jsp?curl=pages/special-topics/general/ general-content-000555.jsp&mid=WC0b01ac0580607bfa.
11. Vedula SS, Li T, Dickersin K. Differences in reporting of analyses in internal company documents versus published trial reports: comparisons in industry-sponsored trials in off-label uses of gabapentin. PLoS Med 2013;10:e1001378.
12. Doshi P, Jones M, Jefferson T. Rethinking credible evidence synthesis. BMJ 2012;344:d7898.
13. Draft recommendation of the European ombudsman 2560/2007/BEH, 2010. www.ombudsman.europa.eu/cases/draftrecommendation.faces/en/4883/html.bookmark.
14. Doshi P, Jefferson T. The first 2 years of the European Medicines Agency's policy on access to documents: secret no longer. JAMA Intern Med 2013;173:380-2.